Man Group plc cut its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 81.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,307 shares of the medical device company's stock after selling 37,115 shares during the quarter. Man Group plc's holdings in Cooper Companies were worth $764,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. T. Rowe Price Investment Management Inc. grew its position in Cooper Companies by 2.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company's stock valued at $705,928,000 after acquiring an additional 155,233 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company's stock valued at $460,066,000 after buying an additional 74,501 shares during the last quarter. Geode Capital Management LLC lifted its position in Cooper Companies by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company's stock worth $449,907,000 after buying an additional 109,907 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Cooper Companies by 14.6% during the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock worth $415,985,000 after purchasing an additional 574,899 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD grew its stake in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company's stock valued at $324,466,000 after purchasing an additional 2,957,421 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.
Cooper Companies Stock Performance
NASDAQ COO traded down $0.47 on Wednesday, reaching $80.12. The stock had a trading volume of 2,434,676 shares, compared to its average volume of 1,502,042. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a fifty day moving average of $80.23 and a two-hundred day moving average of $88.91. The Cooper Companies, Inc. has a 1-year low of $69.81 and a 1-year high of $112.38. The company has a market cap of $16.02 billion, a P/E ratio of 41.09, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.
Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on COO shares. BNP Paribas raised Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Wall Street Zen upgraded Cooper Companies from a "hold" rating to a "buy" rating in a report on Wednesday, May 21st. Piper Sandler reissued an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Finally, Robert W. Baird decreased their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research note on Friday, March 7th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus target price of $110.25.
Get Our Latest Report on Cooper Companies
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
